Fenofibrate-associated reversible acute allograft dysfunction in 3 renal transplant recipients: Biopsy evidence of tubular toxicity

American Journal of Kidney Diseases

Volumn 44, Issue 3, 2004, Pages 543-550

  Angeles, Carmichael ^a   Lane, Bernard P ^b   Miller, Frederick ^b   Nord, Edward P ^a,c  

^a SUNY Downstate Medical Center   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c Division of Nephrology   (United States)

Author keywords

Fenofibrate nephrotoxicity; hyperlipidemia; kidney transplant; reversible allograft dysfunction

Indexed keywords

ALENDRONIC ACID; ALLOPURINOL; AMLODIPINE; ANTILIPEMIC AGENT; AZATHIOPRINE; BENAZEPRIL; CALCINEURIN INHIBITOR; CLONIDINE; CORTICOSTEROID; CREATININE; CYCLOSPORIN A; FAMOTIDINE; FENOFIBRATE; FLUINDOSTATIN; IMMUNOSUPPRESSIVE AGENT; LABETALOL; METOPROLOL; PRAVASTATIN; RAPAMYCIN; VALSARTAN;

ADULT; ANAMNESIS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CASE REPORT; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY PROXIMAL TUBULE; KIDNEY TRANSPLANTATION; LABORATORY TEST; MALE; NEPHROTOXICITY; PATIENT MONITORING; PHYSICAL EXAMINATION; RISK REDUCTION; TUBULAR DYSFUNCTION;

ADULT; ANTILIPEMIC AGENTS; BIOPSY; FEMALE; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; KIDNEY TUBULES, PROXIMAL; MALE; MIDDLE AGED; PROCETOFEN;

EID: 4444231688     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2004.05.040     Document Type: Article

References (21)

1. D.E. Hricik Posttransplant hyperlipidemia The treatment dilemma Am J Kidney Dis 23 1994 766 771
2. K. Kalbak Incidence of arteriosclerosis in patients with rheumatoid arthritis receiving long-term corticosteroid therapy Ann Rheum Dis 31 1972 196 200
3. R. Satterth-Waite, S. Aswad, V. Sunga Incidence of new-onset hypercholesterolemia in renal transplant patients treated with FK506 or cyclosporine Transplantation 55 2000 446 449
4. C. Brattstrom, H.E. Wilczek, G. Tyden, Y. Bottiger, J. Sawe, C.G. Groth Hypertriglyceridemia in renal transplant recipients treated with sirolimus Transplant Proc 30 1998 3950 3951
5. R.J. Howard, P.R. Patton, A.I. Reed The changing causes of graft loss and death after kidney transplantation Transplantation 73 2002 1923 1928
6. R.A. Moore, M.F. Callahan, M. Cody The effect of the American Heart Association step one diet on hyperlipidemia following renal transplantation Transplantation 49 1990 60 62
7. C.M. Barbagallo, A.B. Cefalu, S. Gallo Effects of Mediterranean diet on lipid levels and cardiovascular risk in renal transplant recipients Nephron 82 1999 199 204
8. G.J. Magarian, L.M. Lucas, C. Colley Gemfibrozil-induced myopathy Arch Intern Med 151 1991 1873 1874
9. L.R. Pierce, D.K. Wysowski, T.P. Gross Myopathy and rhabdomyolysis with lovastatin-gemfibrozil combination therapy JAMA 264 1990 71 75
10. O. Devuyst, E. Goffin, Y. Pirson, C. Van Ypersele deStrihou Creatinine rise after fibrate therapy in renal graft recipients Lancet 341 1993 840
11. E.J. Gutmann, J.L. Niles, R.T. McCluskey, D. Brown Colchicine-induced redistribution of an apical membrane glycoprotein(pg330) in proximal tubules Am J Physiol 257 1989 C397 C407
12. E.L. Christensen, A.B. Maunsbach Proteinuria induced by sodium maleate in rats Effects on utrastructure and protein handling in renal proximal tubule Kidney Int 17 1980 771 787
13. G.W. Lipkin, C. Tomson Severe reversible renal failure with bezafibrate Lancet 341 1993 371
14. N. Broeders, C. Knoop, M. Antoine, C. Tielemans, D. Abramowicz Fibrate-induced increase in blood urea and creatinine Is gemfibrozil the only innocuous agent? Nephrol Dial Transplant 15 2000 1993 1999
15. J. Lipscombe, G.F. Lewis, D. Cattran, J.M. Bargman Deterioration in renal function associated with fibrate therapy Clin Nephrol 55 2001 39 44
16. C. Hottelart, N. el Esper, J.M. Achard, A. Pruna, A. Fournier Fenofibrate increases blood creatinine, but does not change glomerular filtration rate in patients with mild renal insufficiency Nephrologie 20 1999 41 44
17. C. Hottelart, N. el Esper, F. Rose, J.M. Achard, A. Fournier Fenofibrate increases creatininemia by increasing metabolic production of creatinine Nephron 92 2002 536 541
18. M. Hirai, E. Tatuso, M. Sakurai, M. Ichikawa, F. Matsuya, Y. Saito Elevated blood concentrations of cyclosporine and kidney failure after benzofibrate in renal graft recipient Ann Pharmacother 30 1996 883 884
19. M. Alonso-Garcia, B. Frohlich, R.J. Roman Induction of P450A activity improves pressure natriuresis in Dahl S rats Hypertension 31 1998 232 236
20. T.W. Wilson, M. Alonso-Garcia, R.J. Roman Effects of lipid-lowering agents in the Dahl salt-sensitive rat Hypertension 31 1998 225 231
21. K.W. Rumpf, M. Barth, M. Blech Benzafibrate-induced myolysis and myoglobinuria in patients with impaired renal function Klin Wochenschr 62 1984 346 348